Deep scalp donor sites can be difficult to manage because of the higher inc
idence of healing complications that can make daily wound care exquisitely
painful. When faced with this problem, we prospectively studied the Unna "c
ap" dressing on the scalp. Group 1 received our standard treatment-Xeroform
gauze (Sherwood Medical, St Louis, Mo) and daily wound care. Group 2 recei
ved the Unna cap-Aquaphor gauze (Beiersdorf, Norwalk, Conn) and Dome Paste
gauze (Bayer Corp, West Haven, Conn) with wound care every 3 days. Pain, he
aling time, and costs were compared. Twelve patients between the ages of 1
and 54 years were studied. A significant number of patients in Group 1 deve
loped wound complications after initial healing, resulting in a longer leng
th of stay and higher costs. Group 2 reported significantly less procedural
pain, comparable healing (11 days +/- 2 SD), and fewer dressing changes, r
esulting in an institutional savings of $5.51 to $16.25 per patient up to p
ostoperative day 13. This study supports use of the Unna cap as a less pain
ful, safe, and cost-effective alternative to our standard deep scalp donor
site dressing.